Cite
Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease.
MLA
Chen, Titi, et al. “Attenuation of Renal Injury by Depleting CDC1 and by Repurposing Flt3 Inhibitor in Anti-GBM Disease.” Clinical Immunology, vol. 250, May 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.clim.2023.109295.
APA
Chen, T., Cao, Q., Wang, R., Zheng, G., Azmi, F., Lee, V. W., Wang, Y. M., Li, H., Yu, D., Rogers, N. M., Alexander, S. I., Harris, D. C. H., & Wang, Y. (2023). Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease. Clinical Immunology, 250, N.PAG. https://doi.org/10.1016/j.clim.2023.109295
Chicago
Chen, Titi, Qi Cao, Ruifeng Wang, Guoping Zheng, Farhana Azmi, Vincent W. Lee, Yuan Ming Wang, et al. 2023. “Attenuation of Renal Injury by Depleting CDC1 and by Repurposing Flt3 Inhibitor in Anti-GBM Disease.” Clinical Immunology 250 (May): N.PAG. doi:10.1016/j.clim.2023.109295.